| 國立交通大學 |
2014-12-08T15:35:29Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Ko, Jen-Chung; Chiu, Hsien-Chun; Syu, Jhan-Jhang; Jian, Yi-Jun; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T14:53:50Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Ko, J.-C. and Chiu, H.-C. and Syu, J.-J. and Jian, Y.-J. and Chen, C.-Y. and Jian, Y.-T. and Huang, Y.-J. and Wo, T.-Y. and Lin, Y.-W.; JEN-CHUNG KO; Chiu, Hsien-Chun; Syu, Jhan-Jhang; Jian, Yi-Jun; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Lin, Yun-Wei |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:38Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Jian Y.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:47Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
1995 |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Pu Y.-S.;Hsieh T.-S.;Tsai T.-C.;Cheng A.-L.;Chang-Yao Hsieh;Su I.-J.;Lai M.-K.; Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; Cheng A.-L.; CHANG-YAO HSIEH; Su I.-J.; Lai M.-K. |
| 臺大學術典藏 |
2021-02-02T00:47:12Z |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Yeong-Shiau Pu;Hsieh T.-S.;Tsai T.-C.;Cheng A.-L.;Hsieh C.-Y.;Su I.-J.;Lai M.-K.; YEONG-SHIAU PU; Hsieh T.-S.; Tsai T.-C.; Cheng A.-L.; Hsieh C.-Y.; Su I.-J.; Lai M.-K. |
| 臺大學術典藏 |
2021-09-01T02:02:44Z |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; ANN-LII CHENG; Hsieh C.-Y.; Su I.-J.; Lai M.-K. |
| 國家衛生研究院 |
2020-05-29 |
Tamoxifen for amyotrophic lateral sclerosis: A randomized double-blind clinical trial
|
Chen, PC;Hsieh, YC;Huang, CC;Hu, CJ |
| 國立交通大學 |
2015-07-21T11:20:28Z |
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells
|
Liu, Chun-Yu; Hung, Man-Hsin; Wang, Duen-Shian; Chu, Pei-Yi; Su, Jung-Chen; Teng, Tsung-Han; Huang, Chun-Teng; Chao, Ting-Ting; Wang, Cheng-Yi; Shiau, Chung-Wai; Tseng, Ling-Ming; Chen, Kuen-Feng |
